Dr. Brian A Van Tine, M.D., Ph.D.
Claim this profileWashington University School of Medicine
About Brian A Van Tine, M.D., Ph.D.
Education:
- Earned an M.D. from the University of Texas Southwestern Medical Center in 2000.
- Obtained a Ph.D. in Cellular and Molecular Biology from the University of Texas Graduate School of Biomedical Sciences in 2000.
Experience:
- Has been an Assistant Professor of Medicine at Washington University School of Medicine since 2009.
- Serving as the Director of the Sarcoma Program at Siteman Cancer Center, Washington University School of Medicine, since 2015.
Area of expertise
Soft Tissue Sarcoma
Brian A Van Tine, M.D., Ph.D. has run 16 trials for Soft Tissue Sarcoma. Some of their research focus areas include:
Cancer
Brian A Van Tine, M.D., Ph.D. has run 11 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Washington University
Clinical Trials Brian A Van Tine, M.D., Ph.D. is currently running
Circulating Tumor DNA
for Cancer
Earlier detection of disease recurrence will enable greater treatment options and has strong potential to improve patient outcomes. This project is translational and has the potential to lead to future translational research opportunities, including interventional trials in which therapeutic escalation is offered at the early circulating tumor DNA (ctDNA) molecular residual disease (MRD) detection timepoint. Ultimately, the integration of ctDNA into the clinical workflow has the potential to enhance cancer diagnosis, treatment, surveillance, and prognosis, and guide clinical decision-making in this era of personalized precision medicine.
Recruiting
1 award
N/A
1 criteria
Registry
for Peripheral Nerve Sheath Tumor
First, the investigators plan to use a retrospective analysis to determine the clinical landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor (MPNST) and precursor lesions (e.g., atypical or nodular plexiform neurofibromas). A worldwide database will be established, collecting, in a standardized manner, histologic, immunohistochemical, molecular, radiographic, treatment, and related clinical data from centers worldwide with expertise in these NF1-related cancers. Although retrospective in nature, the resulting data from this registry may reveal previously unanticipated patterns, similar to the INFACT effort outcome. This registry would then allow the acquisition of data associated with MPNST biospecimens collected under associated banks (frozen or paraffin-embedded, germline (or normal tissue DNA) samples, and any previously somatic whole-exome or whole-genome sequencing data for aggregate analyses). Second, the investigators plan to co-register patients to institutional banks in order to prospectively collect MPNST samples for analysis. These patients will be consented in order to collect the above information and for banking of tumor tissue and future studies that include genomic characterization of the tumors.
Recruiting
1 award
N/A
1 criteria
More about Brian A Van Tine, M.D., Ph.D.
Clinical Trial Related
4 years of experience running clinical trials · Led 49 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Brian A Van Tine, M.D., Ph.D. has experience with
- Cyclophosphamide
- Nivolumab
- Placebo
- Temozolomide
- Pembrolizumab
- Dacarbazine
Breakdown of trials Brian A Van Tine, M.D., Ph.D. has run
Soft Tissue Sarcoma
Cancer
Sarcoma
Pleural Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian A Van Tine, M.D., Ph.D. specialize in?
Brian A Van Tine, M.D., Ph.D. focuses on Soft Tissue Sarcoma and Cancer. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Brian A Van Tine, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Brian A Van Tine, M.D., Ph.D. is currently recruiting for 9 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Brian A Van Tine, M.D., Ph.D. has studied deeply?
Yes, Brian A Van Tine, M.D., Ph.D. has studied treatments such as Cyclophosphamide, Nivolumab, Placebo.
What is the best way to schedule an appointment with Brian A Van Tine, M.D., Ph.D.?
Apply for one of the trials that Brian A Van Tine, M.D., Ph.D. is conducting.
What is the office address of Brian A Van Tine, M.D., Ph.D.?
The office of Brian A Van Tine, M.D., Ph.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.